Status:

COMPLETED

COVID-19 Pandemic Short Interval National Survey Gauging Psychological Distress

Lead Sponsor:

Jon Bailey

Collaborating Sponsors:

Nova Scotia Health Authority

Conditions:

Burnout, Professional

Psychological Distress

Eligibility:

All Genders

Brief Summary

The Coronavirus Disease (COVID-19) pandemic is unprecedented in its scale of infection and the response required to decrease the mortality rates. Disturbingly, the European and United States experienc...

Detailed Description

Background It has become ubiquitous to describe the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and the global measures to decrease mortality rates of Coronavirus Disease (CO...

Eligibility Criteria

Inclusion

  • Any physician who is currently practicing in Canada, whether they hold a full, provisional, or post-graduate in-training license.

Exclusion

  • Non-physician healthcare providers, medical students, physicians without an active license to practice will be excluded.

Key Trial Info

Start Date :

May 13 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 18 2022

Estimated Enrollment :

342 Patients enrolled

Trial Details

Trial ID

NCT04379063

Start Date

May 13 2020

End Date

July 18 2022

Last Update

December 20 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Nova Scotia Health Authority

Halifax, Nova Scotia, Canada, B3S 0H6